Clinical Trial Update: A Study to Evaluate the Tolerability, Safety and Pharmacokinetic Characteristics of DA-3803 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating tolerability, safety, and pharmacokinetics of DA-3803 in infertility with ovulation induction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• DA-3803

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Infertility, Induction of Ovulation | Phase 1 | Status: COMPLETED